Pair Name | Tubeimoside I, TNF-related apoptosis inducing ligand | ||
Phytochemical Name | Tubeimoside I (PubChem CID: 6110917 ) | ||
Anticancer drug Name | TNF-related apoptosis inducing ligand (PubChem CID: / ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Tubeimoside I, TNF-related apoptosis inducing ligand | |||
Disease Info | [ICD-11: 2A00-2F9Z] | Solid tumour or cancer | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Down-regulation | Expression | CFLAR | hsa8837 |
Down-regulation | Expression | STAMBPL1 | hsa57559 | |
In Vitro Model | Caki-1 | Clear cell renal cell carcinoma | Homo sapiens (Human) | CVCL_0234 |
A-549 | Lung adenocarcinoma | Homo sapiens (Human) | CVCL_0023 | |
HeLa | Human papillomavirus-related cervical adenocarcinoma | Homo sapiens (Human) | CVCL_0030 | |
HCT 116 | Colon carcinoma | Homo sapiens (Human) | CVCL_0291 | |
In Vivo Model | Male SCID mice were inoculated subcutaneously at the flank with HCT116 (5×10⁶) cells. | |||
Result | Our study revealed that STAMBPL1 is essential for c-FLIP stabilization, and that STAMBPL1 depletion enhances TRAIL-mediated apoptosis via c-FLIP downregulation. |
No. | Title | Href |
---|---|---|
1 | Tubeimoside-1 Enhances TRAIL-Induced Apoptotic Cell Death through STAMBPL1-Mediated c-FLIP Downregulation. Int J Mol Sci. 2023 Jul 24;24(14):11840. doi: 10.3390/ijms241411840. | Click |